世界の上皮幹細胞市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epithelial Stem Cells Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2240 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、上皮幹細胞のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（吸収細胞、杯細胞、パネート細胞、オリゴデンドロサイト）、用途別市場規模（組織修復損傷、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・上皮幹細胞の市場動向 ・企業の競争状況、市場シェア ・上皮幹細胞の種類別市場規模（吸収細胞、杯細胞、パネート細胞、オリゴデンドロサイト） ・上皮幹細胞の用途別市場規模（組織修復損傷、自己免疫疾患、その他） ・上皮幹細胞の北米市場規模2016-2027（アメリカ、カナダ） ・上皮幹細胞のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・上皮幹細胞のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・上皮幹細胞の中南米市場規模2016-2027（メキシコ、ブラジル） ・上皮幹細胞の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（3Dmatrix、Aldagen、Hybrid Organ、Intellicell Biosciences、Athersys、Beike Biotechnology、Biotime、Brainstorm Cell Therapeutics、Gamida Cell、Capricor、Cellerant Therapeutics、Globalstem、Cellular Dyna、International Stem Cell、Juventas Therapeutics、Mesoblast、Neuralstem、Neurogeneration、Ocata） ・結論

Market Analysis and Insights: Global Epithelial Stem Cells Market
The global Epithelial Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epithelial Stem Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epithelial Stem Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epithelial Stem Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epithelial Stem Cells market.

Global Epithelial Stem Cells Scope and Market Size
Epithelial Stem Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epithelial Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Absorptive Cells
Goblet Cell
Paneth Cells
Oligodendrocytes

Segment by Application
Tissue Repair Damage
Autoimmune Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
3Dmatrix
Aldagen
Hybrid Organ
Intellicell Biosciences
Athersys
Beike Biotechnology
Biotime
Brainstorm Cell Therapeutics
Gamida Cell
Intellicell Biosciences
Athersys
Globalstem
Cellular Dyna
International Stem Cell
Juventas Therapeutics
Mesoblast
Neuralstem

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epithelial Stem Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Absorptive Cells
1.2.3 Goblet Cell
1.2.4 Paneth Cells
1.2.5 Oligodendrocytes
1.3 Market by Application
1.3.1 Global Epithelial Stem Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tissue Repair Damage
1.3.3 Autoimmune Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epithelial Stem Cells Market Perspective (2016-2027)
2.2 Epithelial Stem Cells Growth Trends by Regions
2.2.1 Epithelial Stem Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epithelial Stem Cells Historic Market Share by Regions (2016-2021)
2.2.3 Epithelial Stem Cells Forecasted Market Size by Regions (2022-2027)
2.3 Epithelial Stem Cells Industry Dynamic
2.3.1 Epithelial Stem Cells Market Trends
2.3.2 Epithelial Stem Cells Market Drivers
2.3.3 Epithelial Stem Cells Market Challenges
2.3.4 Epithelial Stem Cells Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epithelial Stem Cells Players by Revenue
3.1.1 Global Top Epithelial Stem Cells Players by Revenue (2016-2021)
3.1.2 Global Epithelial Stem Cells Revenue Market Share by Players (2016-2021)
3.2 Global Epithelial Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epithelial Stem Cells Revenue
3.4 Global Epithelial Stem Cells Market Concentration Ratio
3.4.1 Global Epithelial Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epithelial Stem Cells Revenue in 2020
3.5 Epithelial Stem Cells Key Players Head office and Area Served
3.6 Key Players Epithelial Stem Cells Product Solution and Service
3.7 Date of Enter into Epithelial Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epithelial Stem Cells Breakdown Data by Type
4.1 Global Epithelial Stem Cells Historic Market Size by Type (2016-2021)
4.2 Global Epithelial Stem Cells Forecasted Market Size by Type (2022-2027)

5 Epithelial Stem Cells Breakdown Data by Application
5.1 Global Epithelial Stem Cells Historic Market Size by Application (2016-2021)
5.2 Global Epithelial Stem Cells Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epithelial Stem Cells Market Size (2016-2027)
6.2 North America Epithelial Stem Cells Market Size by Type
6.2.1 North America Epithelial Stem Cells Market Size by Type (2016-2021)
6.2.2 North America Epithelial Stem Cells Market Size by Type (2022-2027)
6.2.3 North America Epithelial Stem Cells Market Size by Type (2016-2027)
6.3 North America Epithelial Stem Cells Market Size by Application
6.3.1 North America Epithelial Stem Cells Market Size by Application (2016-2021)
6.3.2 North America Epithelial Stem Cells Market Size by Application (2022-2027)
6.3.3 North America Epithelial Stem Cells Market Size by Application (2016-2027)
6.4 North America Epithelial Stem Cells Market Size by Country
6.4.1 North America Epithelial Stem Cells Market Size by Country (2016-2021)
6.4.2 North America Epithelial Stem Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Epithelial Stem Cells Market Size (2016-2027)
7.2 Europe Epithelial Stem Cells Market Size by Type
7.2.1 Europe Epithelial Stem Cells Market Size by Type (2016-2021)
7.2.2 Europe Epithelial Stem Cells Market Size by Type (2022-2027)
7.2.3 Europe Epithelial Stem Cells Market Size by Type (2016-2027)
7.3 Europe Epithelial Stem Cells Market Size by Application
7.3.1 Europe Epithelial Stem Cells Market Size by Application (2016-2021)
7.3.2 Europe Epithelial Stem Cells Market Size by Application (2022-2027)
7.3.3 Europe Epithelial Stem Cells Market Size by Application (2016-2027)
7.4 Europe Epithelial Stem Cells Market Size by Country
7.4.1 Europe Epithelial Stem Cells Market Size by Country (2016-2021)
7.4.2 Europe Epithelial Stem Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epithelial Stem Cells Market Size (2016-2027)
8.2 Asia-Pacific Epithelial Stem Cells Market Size by Type
8.2.1 Asia-Pacific Epithelial Stem Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epithelial Stem Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epithelial Stem Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Epithelial Stem Cells Market Size by Application
8.3.1 Asia-Pacific Epithelial Stem Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epithelial Stem Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epithelial Stem Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Epithelial Stem Cells Market Size by Region
8.4.1 Asia-Pacific Epithelial Stem Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epithelial Stem Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epithelial Stem Cells Market Size (2016-2027)
9.2 Latin America Epithelial Stem Cells Market Size by Type
9.2.1 Latin America Epithelial Stem Cells Market Size by Type (2016-2021)
9.2.2 Latin America Epithelial Stem Cells Market Size by Type (2022-2027)
9.2.3 Latin America Epithelial Stem Cells Market Size by Type (2016-2027)
9.3 Latin America Epithelial Stem Cells Market Size by Application
9.3.1 Latin America Epithelial Stem Cells Market Size by Application (2016-2021)
9.3.2 Latin America Epithelial Stem Cells Market Size by Application (2022-2027)
9.3.3 Latin America Epithelial Stem Cells Market Size by Application (2016-2027)
9.4 Latin America Epithelial Stem Cells Market Size by Country
9.4.1 Latin America Epithelial Stem Cells Market Size by Country (2016-2021)
9.4.2 Latin America Epithelial Stem Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epithelial Stem Cells Market Size (2016-2027)
10.2 Middle East & Africa Epithelial Stem Cells Market Size by Type
10.2.1 Middle East & Africa Epithelial Stem Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epithelial Stem Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epithelial Stem Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Epithelial Stem Cells Market Size by Application
10.3.1 Middle East & Africa Epithelial Stem Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epithelial Stem Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epithelial Stem Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Epithelial Stem Cells Market Size by Country
10.4.1 Middle East & Africa Epithelial Stem Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epithelial Stem Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 3Dmatrix
11.1.1 3Dmatrix Company Details
11.1.2 3Dmatrix Business Overview
11.1.3 3Dmatrix Epithelial Stem Cells Introduction
11.1.4 3Dmatrix Revenue in Epithelial Stem Cells Business (2016-2021)
11.1.5 3Dmatrix Recent Development
11.2 Aldagen
11.2.1 Aldagen Company Details
11.2.2 Aldagen Business Overview
11.2.3 Aldagen Epithelial Stem Cells Introduction
11.2.4 Aldagen Revenue in Epithelial Stem Cells Business (2016-2021)
11.2.5 Aldagen Recent Development
11.3 Hybrid Organ
11.3.1 Hybrid Organ Company Details
11.3.2 Hybrid Organ Business Overview
11.3.3 Hybrid Organ Epithelial Stem Cells Introduction
11.3.4 Hybrid Organ Revenue in Epithelial Stem Cells Business (2016-2021)
11.3.5 Hybrid Organ Recent Development
11.4 Intellicell Biosciences
11.4.1 Intellicell Biosciences Company Details
11.4.2 Intellicell Biosciences Business Overview
11.4.3 Intellicell Biosciences Epithelial Stem Cells Introduction
11.4.4 Intellicell Biosciences Revenue in Epithelial Stem Cells Business (2016-2021)
11.4.5 Intellicell Biosciences Recent Development
11.5 Athersys
11.5.1 Athersys Company Details
11.5.2 Athersys Business Overview
11.5.3 Athersys Epithelial Stem Cells Introduction
11.5.4 Athersys Revenue in Epithelial Stem Cells Business (2016-2021)
11.5.5 Athersys Recent Development
11.6 Beike Biotechnology
11.6.1 Beike Biotechnology Company Details
11.6.2 Beike Biotechnology Business Overview
11.6.3 Beike Biotechnology Epithelial Stem Cells Introduction
11.6.4 Beike Biotechnology Revenue in Epithelial Stem Cells Business (2016-2021)
11.6.5 Beike Biotechnology Recent Development
11.7 Biotime
11.7.1 Biotime Company Details
11.7.2 Biotime Business Overview
11.7.3 Biotime Epithelial Stem Cells Introduction
11.7.4 Biotime Revenue in Epithelial Stem Cells Business (2016-2021)
11.7.5 Biotime Recent Development
11.8 Brainstorm Cell Therapeutics
11.8.1 Brainstorm Cell Therapeutics Company Details
11.8.2 Brainstorm Cell Therapeutics Business Overview
11.8.3 Brainstorm Cell Therapeutics Epithelial Stem Cells Introduction
11.8.4 Brainstorm Cell Therapeutics Revenue in Epithelial Stem Cells Business (2016-2021)
11.8.5 Brainstorm Cell Therapeutics Recent Development
11.9 Gamida Cell
11.9.1 Gamida Cell Company Details
11.9.2 Gamida Cell Business Overview
11.9.3 Gamida Cell Epithelial Stem Cells Introduction
11.9.4 Gamida Cell Revenue in Epithelial Stem Cells Business (2016-2021)
11.9.5 Gamida Cell Recent Development
11.10 Capricor
11.10.1 Capricor Company Details
11.10.2 Capricor Business Overview
11.10.3 Capricor Epithelial Stem Cells Introduction
11.10.4 Capricor Revenue in Epithelial Stem Cells Business (2016-2021)
11.10.5 Capricor Recent Development
11.11 Cellerant Therapeutics
11.11.1 Cellerant Therapeutics Company Details
11.11.2 Cellerant Therapeutics Business Overview
11.11.3 Cellerant Therapeutics Epithelial Stem Cells Introduction
11.11.4 Cellerant Therapeutics Revenue in Epithelial Stem Cells Business (2016-2021)
11.11.5 Cellerant Therapeutics Recent Development
11.12 Globalstem
11.12.1 Globalstem Company Details
11.12.2 Globalstem Business Overview
11.12.3 Globalstem Epithelial Stem Cells Introduction
11.12.4 Globalstem Revenue in Epithelial Stem Cells Business (2016-2021)
11.12.5 Globalstem Recent Development
11.13 Cellular Dyna
11.13.1 Cellular Dyna Company Details
11.13.2 Cellular Dyna Business Overview
11.13.3 Cellular Dyna Epithelial Stem Cells Introduction
11.13.4 Cellular Dyna Revenue in Epithelial Stem Cells Business (2016-2021)
11.13.5 Cellular Dyna Recent Development
11.14 International Stem Cell
11.14.1 International Stem Cell Company Details
11.14.2 International Stem Cell Business Overview
11.14.3 International Stem Cell Epithelial Stem Cells Introduction
11.14.4 International Stem Cell Revenue in Epithelial Stem Cells Business (2016-2021)
11.14.5 International Stem Cell Recent Development
11.15 Juventas Therapeutics
11.15.1 Juventas Therapeutics Company Details
11.15.2 Juventas Therapeutics Business Overview
11.15.3 Juventas Therapeutics Epithelial Stem Cells Introduction
11.15.4 Juventas Therapeutics Revenue in Epithelial Stem Cells Business (2016-2021)
11.15.5 Juventas Therapeutics Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Epithelial Stem Cells Introduction
11.16.4 Mesoblast Revenue in Epithelial Stem Cells Business (2016-2021)
11.16.5 Mesoblast Recent Development
11.17 Neuralstem
11.17.1 Neuralstem Company Details
11.17.2 Neuralstem Business Overview
11.17.3 Neuralstem Epithelial Stem Cells Introduction
11.17.4 Neuralstem Revenue in Epithelial Stem Cells Business (2016-2021)
11.17.5 Neuralstem Recent Development
11.18 Neurogeneration
11.18.1 Neurogeneration Company Details
11.18.2 Neurogeneration Business Overview
11.18.3 Neurogeneration Epithelial Stem Cells Introduction
11.18.4 Neurogeneration Revenue in Epithelial Stem Cells Business (2016-2021)
11.18.5 Neurogeneration Recent Development
11.18 Ocata
.1 Ocata Company Details
.2 Ocata Business Overview
.3 Ocata Epithelial Stem Cells Introduction
.4 Ocata Revenue in Epithelial Stem Cells Business (2016-2021)
.5 Ocata Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epithelial Stem Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Absorptive Cells
Table 3. Key Players of Goblet Cell
Table 4. Key Players of Paneth Cells
Table 5. Key Players of Oligodendrocytes
Table 6. Global Epithelial Stem Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Epithelial Stem Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Epithelial Stem Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Epithelial Stem Cells Market Share by Regions (2016-2021)
Table 10. Global Epithelial Stem Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Epithelial Stem Cells Market Share by Regions (2022-2027)
Table 12. Epithelial Stem Cells Market Trends
Table 13. Epithelial Stem Cells Market Drivers
Table 14. Epithelial Stem Cells Market Challenges
Table 15. Epithelial Stem Cells Market Restraints
Table 16. Global Epithelial Stem Cells Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Epithelial Stem Cells Market Share by Players (2016-2021)
Table 18. Global Top Epithelial Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Stem Cells as of 2020)
Table 19. Ranking of Global Top Epithelial Stem Cells Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Epithelial Stem Cells Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Epithelial Stem Cells Product Solution and Service
Table 23. Date of Enter into Epithelial Stem Cells Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Epithelial Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Epithelial Stem Cells Revenue Market Share by Type (2016-2021)
Table 27. Global Epithelial Stem Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Epithelial Stem Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Epithelial Stem Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Epithelial Stem Cells Revenue Market Share by Application (2016-2021)
Table 31. Global Epithelial Stem Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Epithelial Stem Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Epithelial Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Epithelial Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Epithelial Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Epithelial Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Epithelial Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Epithelial Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Epithelial Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Epithelial Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Epithelial Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Epithelial Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Epithelial Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Epithelial Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epithelial Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epithelial Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epithelial Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Epithelial Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Epithelial Stem Cells Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Epithelial Stem Cells Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Epithelial Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Epithelial Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Epithelial Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Epithelial Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Epithelial Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Epithelial Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epithelial Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epithelial Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epithelial Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Epithelial Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Epithelial Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Epithelial Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 63. 3Dmatrix Company Details
Table 64. 3Dmatrix Business Overview
Table 65. 3Dmatrix Epithelial Stem Cells Product
Table 66. 3Dmatrix Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 67. 3Dmatrix Recent Development
Table 68. Aldagen Company Details
Table 69. Aldagen Business Overview
Table 70. Aldagen Epithelial Stem Cells Product
Table 71. Aldagen Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 72. Aldagen Recent Development
Table 73. Hybrid Organ Company Details
Table 74. Hybrid Organ Business Overview
Table 75. Hybrid Organ Epithelial Stem Cells Product
Table 76. Hybrid Organ Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 77. Hybrid Organ Recent Development
Table 78. Intellicell Biosciences Company Details
Table 79. Intellicell Biosciences Business Overview
Table 80. Intellicell Biosciences Epithelial Stem Cells Product
Table 81. Intellicell Biosciences Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 82. Intellicell Biosciences Recent Development
Table 83. Athersys Company Details
Table 84. Athersys Business Overview
Table 85. Athersys Epithelial Stem Cells Product
Table 86. Athersys Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 87. Athersys Recent Development
Table 88. Beike Biotechnology Company Details
Table 89. Beike Biotechnology Business Overview
Table 90. Beike Biotechnology Epithelial Stem Cells Product
Table 91. Beike Biotechnology Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 92. Beike Biotechnology Recent Development
Table 93. Biotime Company Details
Table 94. Biotime Business Overview
Table 95. Biotime Epithelial Stem Cells Product
Table 96. Biotime Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 97. Biotime Recent Development
Table 98. Brainstorm Cell Therapeutics Company Details
Table 99. Brainstorm Cell Therapeutics Business Overview
Table 100. Brainstorm Cell Therapeutics Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 101. Brainstorm Cell Therapeutics Recent Development
Table 102. Gamida Cell Company Details
Table 103. Gamida Cell Business Overview
Table 104. Gamida Cell Epithelial Stem Cells Product
Table 105. Gamida Cell Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 106. Gamida Cell Recent Development
Table 107. Capricor Company Details
Table 108. Capricor Business Overview
Table 109. Capricor Epithelial Stem Cells Product
Table 110. Capricor Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 111. Capricor Recent Development
Table 112. Cellerant Therapeutics Company Details
Table 113. Cellerant Therapeutics Business Overview
Table 114. Cellerant Therapeutics Epithelial Stem Cells Product
Table 115. Cellerant Therapeutics Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 116. Cellerant Therapeutics Recent Development
Table 117. Globalstem Company Details
Table 118. Globalstem Business Overview
Table 119. Globalstem Epithelial Stem Cells Product
Table 120. Globalstem Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 121. Globalstem Recent Development
Table 122. Cellular Dyna Company Details
Table 123. Cellular Dyna Business Overview
Table 124. Cellular Dyna Epithelial Stem Cells Product
Table 125. Cellular Dyna Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 126. Cellular Dyna Recent Development
Table 127. International Stem Cell Company Details
Table 128. International Stem Cell Business Overview
Table 129. International Stem Cell Epithelial Stem Cells Product
Table 130. International Stem Cell Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 131. International Stem Cell Recent Development
Table 132. Juventas Therapeutics Company Details
Table 133. Juventas Therapeutics Business Overview
Table 134. Juventas Therapeutics Epithelial Stem Cells Product
Table 135. Juventas Therapeutics Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 136. Juventas Therapeutics Recent Development
Table 137. Mesoblast Company Details
Table 138. Mesoblast Business Overview
Table 139. Mesoblast Epithelial Stem Cells Product
Table 140. Mesoblast Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 141. Mesoblast Recent Development
Table 142. Neuralstem Company Details
Table 143. Neuralstem Business Overview
Table 144. Neuralstem Epithelial Stem Cells Product
Table 145. Neuralstem Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 146. Neuralstem Recent Development
Table 147. Neurogeneration Company Details
Table 148. Neurogeneration Business Overview
Table 149. Neurogeneration Epithelial Stem Cells Product
Table 150. Neurogeneration Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 151. Neurogeneration Recent Development
Table 152. Ocata Company Details
Table 153. Ocata Business Overview
Table 154. Ocata Epithelial Stem Cells Product
Table 155. Ocata Revenue in Epithelial Stem Cells Business (2016-2021) & (US$ Million)
Table 156. Ocata Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epithelial Stem Cells Market Share by Type: 2020 VS 2027
Figure 2. Absorptive Cells Features
Figure 3. Goblet Cell Features
Figure 4. Paneth Cells Features
Figure 5. Oligodendrocytes Features
Figure 6. Global Epithelial Stem Cells Market Share by Application: 2020 VS 2027
Figure 7. Tissue Repair Damage Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Epithelial Stem Cells Report Years Considered
Figure 11. Global Epithelial Stem Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Epithelial Stem Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Epithelial Stem Cells Market Share by Regions: 2020 VS 2027
Figure 14. Global Epithelial Stem Cells Market Share by Regions (2022-2027)
Figure 15. Global Epithelial Stem Cells Market Share by Players in 2020
Figure 16. Global Top Epithelial Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Stem Cells as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Epithelial Stem Cells Revenue in 2020
Figure 18. Global Epithelial Stem Cells Revenue Market Share by Type (2016-2021)
Figure 19. Global Epithelial Stem Cells Revenue Market Share by Type (2022-2027)
Figure 20. North America Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Epithelial Stem Cells Market Share by Type (2016-2027)
Figure 22. North America Epithelial Stem Cells Market Share by Application (2016-2027)
Figure 23. North America Epithelial Stem Cells Market Share by Country (2016-2027)
Figure 24. United States Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Epithelial Stem Cells Market Share by Type (2016-2027)
Figure 28. Europe Epithelial Stem Cells Market Share by Application (2016-2027)
Figure 29. Europe Epithelial Stem Cells Market Share by Country (2016-2027)
Figure 30. Germany Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Epithelial Stem Cells Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Epithelial Stem Cells Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Epithelial Stem Cells Market Share by Region (2016-2027)
Figure 40. China Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Epithelial Stem Cells Market Share by Type (2016-2027)
Figure 48. Latin America Epithelial Stem Cells Market Share by Application (2016-2027)
Figure 49. Latin America Epithelial Stem Cells Market Share by Country (2016-2027)
Figure 50. Mexico Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Epithelial Stem Cells Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Epithelial Stem Cells Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Epithelial Stem Cells Market Share by Country (2016-2027)
Figure 56. Turkey Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Epithelial Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. 3Dmatrix Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 60. Aldagen Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 61. Hybrid Organ Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 62. Intellicell Biosciences Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 63. Athersys Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 64. Beike Biotechnology Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 65. Biotime Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 66. Brainstorm Cell Therapeutics Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 67. Gamida Cell Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 68. Capricor Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 69. Cellerant Therapeutics Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 70. Globalstem Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 71. Cellular Dyna Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 72. International Stem Cell Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 73. Juventas Therapeutics Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 74. Mesoblast Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 75. Neuralstem Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 76. Neurogeneration Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 77. Ocata Revenue Growth Rate in Epithelial Stem Cells Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

---